跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LAMICTAL 50 MG COMPRIMIDOS MASTICABLES/DISPERSABLES - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LAMICTAL 50 MG COMPRIMIDOS MASTICABLES/DISPERSABLES
Approved
STANDARD
LAMICTAL 50 MG COMPRIMIDOS MASTICABLES/DISPERSABLES
Glaxosmithkline Gmbh & Co. Kg
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 27, 2024
Approval ID
7b1fab146f2a6e52
Company
Glaxosmithkline Gmbh & Co. Kg
Type
Standard
Approval Details
Approval Id
7b1fab146f2a6e52
Drug Cima Aemps Name
LAMICTAL 50 MG COMPRIMIDOS MASTICABLES/DISPERSABLES
Register Number
331220200IP
Holder Company Name
Glaxosmithkline Gmbh & Co. Kg
Marketing Company Name
Euromed Pharma Spain S.L.
Holder Company Detail Path
/organization/glaxosmithkline-gmbh-and-co-kg
Authorization Date
2024-05-27
Dosage Form
COMPRIMIDO MASTICABLE Y DISPERSABLE
Dose
50 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
No
Company Name
Glaxosmithkline Gmbh & Co. Kg
Company Detail Path
/organization/glaxosmithkline-gmbh-and-co-kg
Company Information
Pharmaceutical Company Name
GlaxoSmithKline GmbH & Co. KG
Country Name
Germany
City Name
hamburg,hamburg,country_de
Address
Heidenkampsweg 51
Active Ingredients
LAMOTRIGINA
50 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 27, 2024
Approval ID
7b1fab146f2a6e52
Type
Standard
Back to CIMA-AEMPS Approvals